首页> 外文期刊>Bone marrow transplantation >Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine.
【24h】

Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine.

机译:使用低剂量全身照射和氟达拉滨进行调理后,T细胞贫血的异基因造血干细胞移植后稳定的混合嵌合体。

获取原文
获取原文并翻译 | 示例
       

摘要

Although reduced intensity conditioning (RIC) before allografting is associated with low treatment-related morbidity and mortality, graft-versus-host disease (GVHD) remains a significant complication of hematopoietic stem cell transplantation (HSCT). T cell depletion (TCD) has been successfully used in conventional allotransplantation to reduce the incidence of GVHD, but was associated with an increased rate of engraftment failure. In a small cohort of six patients at high risk of developing GVHD we have determined whether sustained engraftment could be achieved using reduced intensity conditioning and T cell depletion in combination. All patients engrafted and 5/6 developed high levels (ie >/=95%) of donor chimerism, even though mismatched related or matched unrelated donors were used. Only one patient developed acute GVHD, as he received donor lymphocyte infusions (DLI) for relapse. In summary, TCD might be a useful prophylactic tool in RIC allogeneic HSCT. Although TCD after RIC might be associated with high relapse rate, as 5/6 patients are not in remission, this combined strategy might be appropriate for patients with less aggressive malignant or non-malignant diseases in which high transplant-related morbidity and mortality is not acceptable.
机译:尽管同种异体移植前降低强度调节(RIC)与治疗相关的发病率和死亡率低有关,但移植物抗宿主病(GVHD)仍然是造血干细胞移植(HSCT)的重要并发症。 T细胞耗竭(TCD)已成功用于常规同种异体移植以降低GVHD的发生率,但与移植失败率增加相关。在六名高危人群发生GVHD的患者队列中,我们确定了通过降低强度调节和结合T细胞耗竭是否可以实现持续植入。即使使用了不匹配的相关或匹配的不相关供体,所有植入的患者和5/6的供体嵌合体水平都很高(即> / = 95%)。只有一名患者因接受供体淋巴细胞输注(DLI)复发而发展为急性GVHD。总之,TCD可能是RIC同种异体HSCT的有用预防工具。尽管RIC后的TCD可能与复发率高有关,因为5/6的患者没有缓解,但是这种联合策略可能适用于侵袭性较弱或非恶性疾病的患者,这些患者的移植相关发病率和死亡率均不高可以接受的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号